Prelude Capital Management’s Day One Biopharmaceuticals DAWN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$127K	Buy	+19,539	New	+$127K	0.01%	870
2024 Q1	–	Sell	-42,500	Closed	-$621K	–	1244
2023 Q4	$621K	Buy	42,500 +20,600	+94%	+$301K	0.04%	359
2023 Q3	$269K	Buy	21,900 +10,000	+84%	+$123K	0.02%	617
2023 Q2	$142K	Buy	+11,900	New	+$142K	0.01%	775